Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:748616.
doi: 10.1155/2011/748616. Epub 2010 Dec 19.

Oncologic outcomes of asian men with clinically localized prostate cancer after extraperitoneal laparoscopic radical prostatectomy: a single-institution experience

Huai-Ching Tai  1 , Ming-Kuen Lai, Chao-Yuan Huang, Shuo-Meng Wang, Kuo-How Huang, Shiu-Dong Chung, Shih-Chieh Jeff Chueh, Hong-Jeng Yu
Affiliations

Oncologic outcomes of asian men with clinically localized prostate cancer after extraperitoneal laparoscopic radical prostatectomy: a single-institution experience

Huai-Ching Tai et al. Prostate Cancer. 2011.

Abstract

Purpose. To evaluate the midterm oncologic results of extraperitoneal laparoscopic radical prostatectomy (EPLRP) for Asian men with localized prostate cancer. Methods. Between 2004 and 2009, 218 men underwent EPLRP at an Asian tertiary hospital. The mean preoperative prostate-specific antigen (PSA) was 15.5 ng/ml and mean Gleason score was 6.6. Stage distributions were cT1a-b in 21 cases, cT1c in 139, cT2 in 48 and cT3 in 10. Disease recurrence was defined as PSA ≥ 0.2 ng/mL in 2 consecutive measurements or initiation of secondary therapy. Results. Postoperative pathological stage was pT2a-b in 33 patients, pT2cN0 in 10, pT3a in 27, pT3b in 36, pT4 in 9 and pN1 in 10. Positive surgical margins occurred in 14.6% and 48.6% for pT2 and pT3 diseases, respectively (P < .001). The overall PSA recurrence-free survival at 3 and 5 years was 82.1% and 74.5%. By the pathological stages, 3-year recurrence-free survival was 92.4% (pT2), 81.1% (pT3a), 62.6% (pT3b-4) and 55.6% (pN1), respectively (P < .001). Conclusions. EPLRP is curative even for some locally advanced prostate cancers in a midterm follow-up. Even at an Asian center of low volume of radical prostatectomy EPLRP still provides oncologic outcomes similar to that of high volume centers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PSA recurrence-free survival after EPLRP in Taiwanese men.
Figure 2
Figure 2
PSA recurrence-free survival stratified by preoperative PSA level.
Figure 3
Figure 3
PSA recurrence-free survival stratified by pathological stage.
Figure 4
Figure 4
PSA recurrence-free survival stratified by Gleason score.
Figure 5
Figure 5
PSA recurrence-free survival stratified by surgical margin status.
Figure 6
Figure 6
PSA recurrence-free survival stratified by the presence of perineural invasion (PNI).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Taiwan Cancer Registry: Annual Reports of Taiwan Cancer Registry. http://tcr.cph.ntu.edu.tw/uploadimages/Year_Male%20genital.xls.
    1. Richie JP. Localized prostate cancer: overview of surgical management. Urology. 1997;49(3):35–37. - PubMed
    1. Korman HJ, Leu PB, Huang RR, Goldstein NS. A centralized comparison of radical perineal and retropubic prostatectomy specimens: is there a difference according to the surgical approach? Journal of Urology. 2002;168(3):991–994. - PubMed
    1. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate. 1983;4(5):473–485. - PubMed
    1. Eggleston JC, Walsh PC. Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases. Journal of Urology. 1985;134(6):1146–1148. - PubMed